Download SilvaSorb® Site - Safe Home Products

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Infection control wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Transcript
SilvaSorb Site
®
Ionic silver percutaneous site protection.
The difference is clear.
A
A dressing
dressing that
that helps
helps fight
fight infection
infection at
at
port
& catheter
sites.
pin,pin,
port
& catheter
sites.
SilvaSorb® Site dressings can help reduce the risk of infection at I.V. insertion sites and other
indwelling percutaneous devices. Advanced technology provides controlled, sustained-release of
antimicrobial ionic silver, killing infection-causing bacteria, yeast and fungi for up to seven days
without harming tissue cells.
SilvaSorb dressings have been shown to reduce bacterial counts by
99.99% within 2 hours (data on file), even on intact skin as silver
release is induced by moisture transpired by the skin.
Infection statistics:
According to the Centers for Disease Control and Prevention (CDC),
an estimated 250,000 cases of bloodstream infections associated
with central venous catheters occur each year in U.S. hospitals.
SilvaSorb is fast acting.
These infections add approximately $25,000 in patient care costs
per episode. And, the mortality associated with these infections is
18% or 45,000 deaths per year. (CDC, Guidelines for the
Prevention of Intravascular Catheter-Related Infections, Recommendations and Reports,
Morbidity and Mortality Weekly Report, August 9, 2002,Vol. 51, No. RR-10)
1
A snug fit means less room for bacteria to enter
Gap
The SilvaSorb Site dressing is available in two sizes.The one-inch circular pad with a 4-mm center saddle and a radial
slit allows full contact between the dressing and the indwelling device, with little to no gap where bacteria could easily
enter.The 1.75” circular pad with starburst and radial slit accommodates larger devices such as ports, gastrostomy tubes
Gap
or large bore needles.
Partial contact vs. complete coverage
Gap
While other site dressings may leave gaps that can serve as
potential entry points for bacteria, the SilvaSorb Site is
designed to reduce this vulnerability.
No Gap
No Gap
Gap
Competitive Device
SilvaSorb Site
No Gap
Important features and benefits of SilvaSorb Site dressings
No Gap
Feature
Benefit
Sustained release of ionic silver
Broad-spectrum antimicrobial protection for up to 7 days1,7
Self-activating, self-regulating
Requires no wetting or re-wetting to activate,2
reduces skin bioburden without wetting
Full-contact saddle & starburst design
Eliminates gaps; helps keep bacteria out
Thin, flexible material
Lies flat for a comfortable, secure fit
Translucent
Easy to monitor insertion site
Non-staining
No discoloration of site to interfere with assessment
Super-absorbent, polyacrylate
Maintains optimal moisture balance 1
Non-adherent
Pain-free removal
Non-toxic, non-irritating, non-sensitizing
Improved patient safety and comfort 1
Contains no CHG
Less chance for irritation
How do SilvaSorb Site dressings compare to other insertion site dressings?
Antimicrobial ingredients. SilvaSorb Site utilizes ionic silver, a proven antimicrobial agent7 that is non-irritating.
Some dressings use chlorhexidine gluconate (CHG) to kill bacteria.This is a common antiseptic that can cause
hypersensitivity reactions and has not been proven safe for use on children.3,4,5
Material. SilvaSorb Site dressing is made of a thin, flexible, translucent, hydrophilic material that allows for visualization
and monitoring of the insertion site. It lies flat and conforms to the site for greater comfort and a secure fit. By contrast,
other dressings are made of thick, opaque foam that are bulky and do not allow site monitoring.
Design. SilvaSorb Site dressings have a unique “saddle design” that provides complete contact at the insertion site.
The physical design combined with the antimicrobial activity reduces the risk of bacteria migrating into the site. Other
insertion site dressings have a simple hole in the middle, which can create a gap between the dressing and the catheter
or other device.
Where can I use SilvaSorb Site dressings?
Use SilvaSorb Site dressings with the
following devices:
Vascular devices
• I.V. catheters
• Peripheral catheters
• PICC lines
• Central venous (CV) lines
• Arterial catheters
• Dialysis catheters
• Other indwelling catheters
Non-vascular percutaneous devices
• Peritoneal dialysis catheters
• Epidural catheters
• Chest tubes
• Gastrostomy feeding tubes
• External fixator pins
Use Sureview I.V. dressings to cover and
secure your SilvaSorb Site dressing.
Clinical use of SilvaSorb Site
Use on burn and pediatric patients:
• Dressing use on 47 adult burn patients proved ease of use, cost-effectiveness,
and prevention of local or Catheter Related Bloodstream Infection (CRBSI)
in all patients.6
• Site dressing use on 14 pediatric patients showed ease of use, lack of local reactions,
and zero incidence of local or systemic infection.8
Ordering information
Item No.
Description
HCPCS
Pkg.
MSC9310EP
1" disc with 4-mm center saddle and radial slit
A6242
30/cs
A6242
30/cs
For larger devices (5-13 mm) such as gastric feeding tubes:
MSC9320EP
13/4" disc with center hole
How easy is it to use?
Application is quick and simple:
• Wrap dressing around insertion site
• Overlap the sides around the insertion device
or catheter hub
• Cover and secure with transparent film
(such as Sureview™ I.V. dressings)
• Remove every 7 days (more often if heavy
exudate is present)
1” Disc (actual size)
1 3/4” Disc (actual size)
Gentle effectiveness within a reasonable time
Candida albicans
2
4.27
0
0
2.27
E. coli
Quantitative
using4 the AATCC-100
4
6 recovery
8 measurements on microorganisms
2
6
8 method shows that SilvaSorb Site
4.26
4.2
4.29
Control
6.2
6.15
5.98
6.2
demonstrates similar effectiveness (log reduction) as the CHG containing site dressing within hours of contact with
0
0
0
Biopatch
0
0
0
0
7
the test microorganisms.This
performance
is also similar
or better
than
1.6
0
0
Silver Site
0
0
0 the other
0 silver-based site during testing.
1.39
0
0
SilvaSorb Site
0
0
Candida albicans
0
0
E. coli
Candida albicans
E. coli
5
7
6
Control
Biopatch
Silver Site
SilvaSorb Site
Log10
3
2
1
0
aecalis (Vancomycin
Resistant)
-1
2
5.09
0
4.89
4.5
4
5.14
0
4.54
2.48
62
5.1
0
4.23
0
Pseudomonas
4 8
5.19
Hours
0
4.04
0
6
8
Control
Biopatch
Silver Site
SilvaSorb Site
2
5.74
0
0
0
Log10
4
5
4
3
2
1
0
aeruginosa
-1
Entercoccus faecalis (Vancomycin resistent)
4
5.69
0
0
0
Control
Biopatch
Silver Site
SilvaSorb Site
62
4.6
0
0
0
7
6
Log10
4
Control
Biopatch
Silver Site
SilvaSorb Site
3
2
1
0
62
6.27
0
0
0
4 8
6.4
Hours
0
0
0
6
Log10
5
4
6.41
0
3.87
0
* Biopatch, Silver Site
and SilvaSorb Site
all register at “0”
Pseudomonas aeruginosa
6
5
4
3
2
Control
Biopatch
Silver Site
SilvaSorb Site
1
0
-1
8
2
4
6
8
Hours*
* Biopatch, Silver Site
and SilvaSorb Site
all register at “0”
References
Staphylococcus aureus
1. Internal Report on File.
2. Skin Bioburden Reduction Test, Acryderm Silver Antimicrobial Dressing.
Technical Report 01/138, 2001.
Staphylococcus aureus
3. Garland JS, Alex CP, Mueller CD, Otten D, Shivpui C, Harris MC, Naples M, Pellegrini J,
Buck RK, McAuliffe TL, Goldmann DA, Maki DG. A randomized trial comparing
povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of
central venous catheter infections in neonates. Pediatrics. 2001; 107(6): 1431-1436.
7
6
Log10
2
6.2
0
5.18
5.14
8
Pseudomonas aeruginosa
Entercoccus faecalis (Vancomycin Resistant)
phylococcus aureus
-1
4 8
6
4.42
Hours*
0
0
0
5
4
3
2
Control
Biopatch
Silver Site
SilvaSorb Site
1
0
-1
4. Garland JS, Alex CP, Mueller CD, Cisier-Kahill LA. Local reactions to a chlorhexidine
gluconate-impregnated antimicrobial dressing in very low birth weight infants.
Pediatric Infectious Disease Journal. 1996; 15(109): 912-914.
5. FDA” U.S. Food and Drug Administration.The Public Health Notifications page.
Available at: http://www.fda.gov/cdrh/chlorhex.heml. Accessed November 13, 2007.
6. Wilson J, Friedman B, et al. An evaluation of the new SilvaSorb Site dressing for use in
adult burn patients.The Joseph M Still Research Foundation, Augusta, GA, 2006.
2
4
6
8
Hours
7. Internal Report, AATCC 100 testing, Report #648/10R, 2006.
8. Copty T, Kiran RV, Glat P. Assessing the risk of skin irritation with the use of a silver
based site dressing on pediatric patients. Symposium on Advanced Wound Care.
San Antonio. 2006.
To learn more about SilvaSorb antimicrobial dressings, including SilvaSorb Sheets, SilvaSorb Cavity,
and SilvaSorb Gel, ask your Medline representative for a copy of our full-line brochure.
Or, visit our website: www.medline.com/woundcare
Targeted
antimicrobial protection
1-800-MEDLINE | www.medline.com
©2008 Medline Industries, Inc. One Medline Place, Mundelein, IL 60060
Medline is a registered trademark of Medline Industries, Inc.
SilvaSorb and MicroLattice are trademarks of AcryMed, Inc.
MKT207330 / LIT145 / 3ZPN / 10M